
Company valuation, historical trends, and peer comparisons.
According to Novacyt S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 27.28M. This represents a change of 6.43% compared to the average of 25.63M of the last 4 quarters.
The mean historical Enterprise Value of Novacyt S.A. over the last ten years is 92.14M. The current 27.28M Enterprise Value has changed -70.40% with respect to the historical average. Over the past ten years (40 quarters), NVYTF's Enterprise Value was at its highest in in the December 2020 quarter at 603.01M. The Enterprise Value was at its lowest in in the June 2023 quarter at -52600765.85.
Average
92.14M
Median
19.02M
Minimum
733.97K
Maximum
578.85M
Discovering the peaks and valleys of Novacyt S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.31%
Maximum Annual Enterprise Value = 578.85M
Minimum Annual Increase = -99.65%
Minimum Annual Enterprise Value = 733.97K
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 18.92M | -20.96% |
| 2024 | 23.94M | 19.67% |
| 2023 | 20.01M | 2.63% |
| 2022 | 733.97K | -99.65% |
| 2021 | 209.47M | -63.81% |
| 2020 | 578.85M | 3.31% |
| 2019 | 16.97M | -7.43% |
| 2018 | 18.33M | 21.91% |
| 2017 | 15.03M | -21.36% |
| 2016 | 19.12M | -18.78% |
The current Enterprise Value of Novacyt S.A. (NVYTF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.96M
5-year avg
54.61M
10-year avg
92.14M
Novacyt S.A.’s Enterprise Value is less than Theralase Technologies Inc. (52.33M), greater than Vivos Inc. (18.77M), greater than Drug Free Solution, Inc. (100.86K), less than Medical Developments International Limited (32.36M), greater than PetVivo Holdings, Inc. (25.36M), less than Nova Eye Medical Limited (41.32M), less than iAnthus Capital Holdings, Inc. (258.93M), less than CubeSmart (13.97B), greater than ImpediMed Limited (15.97M), less than Sernova Corp. (42.17M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 52.33M | $43.47M | |
| 18.77M | $21.00M | |
| 100.86K | $113.36K | |
| 32.36M | $30.67M | |
| 25.36M | $24.97M | |
| 41.32M | $4.08M | |
| 258.93M | $27.90M | |
| 13.97B | $14.48M | |
| 15.97M | $9.53M | |
| 42.17M | $30.21M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novacyt S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novacyt S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Novacyt S.A.'s Enterprise Value?
What is the highest Enterprise Value for Novacyt S.A. (NVYTF)?
What is the 3-year average Enterprise Value for Novacyt S.A. (NVYTF)?
What is the 5-year average Enterprise Value for Novacyt S.A. (NVYTF)?
How does the current Enterprise Value for Novacyt S.A. (NVYTF) compare to its historical average?